Isis Pharma (ISIS) Tops Q4 EPS by 23c
Tweet
Share
E-mailGet Alerts ISIS Hot Sheet
Price: $57.56 --0%
Financial Fact:
Basic net loss (in dollars per share): 0.06
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Basic net loss (in dollars per share): 0.06
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Isis Pharma (NASDAQ: ISIS) reported Q4 EPS of $0.25, $0.23 better than the analyst estimate of $0.02. Revenue for the quarter came in at $84.9 million versus the consensus estimate of $74.58 million.
For earnings history and earnings-related data on Isis Pharma (ISIS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Rothschild Redburn Upgrades Apple (AAPL) to Buy
- Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
